S100A4 mRNA is a Diagnostic and Prognostic Marker in Pancreatic Carcinoma
Authors:
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 13 (10) , 1852-1858
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancerWorld Journal of Gastroenterology, 2008
- Over‐expression of S100A2 in pancreatic cancer correlates with progression and poor prognosisThe Journal of Pathology, 2007
- S100A4 Contributes to the Suppression of BNIP3 Expression, Chemoresistance, and Inhibition of Apoptosis in Pancreatic CancerCancer Research, 2007
- Molecular prognostic markers in pancreatic cancer: A systematic reviewEuropean Journal of Cancer, 2005
- Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin FormationJournal of Biological Chemistry, 2005
- Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samplesGut, 2004
- A new molecular biology approach in morphology: basic method and application of laser microdissectionMedical Molecular Morphology, 2004
- Biliary brushing cytologyCytopathology, 2004
- Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancerThe Journal of Pathology, 2002
- Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cellsOncogene, 1997